Martin-Broto, J, Ospina, GM, Garcia, AS, Trufero, JM, Martinez-Garcia, J, Fidalgo, JAP, Morales, CMV, Jurado, JC, Ledesma, P, Grifman, M, Moura, DD, Muñiz, NH. CIRTUSARC: A multicenter, open-label phase II trial of cirtuvivint as second-line therapy in selected advanced soft-tissue sarcomas. ANNALS OF ONCOLOGY. 2025; 36DOI:10.1016/j.annonc.2025.08.3354. PMID:. IF:65.400(Q1/1D).

Farré, A, Huguet, J, Basile, G, Diéguez, L, Izquierdo, P, Sánchez, R, Gavrilov, P, Gallioli, A, Faba, OR, Gaya, JM, Palou, J, Breda, A. Oncological outcomes for patients with European Association of Urology definitions of BCG failure treated with radical cystectomy. Actas Urologicas Espanolas. 2025; 49(9)DOI:10.1016/j.acuro.2025.501834. PMID:. IF:1.200(Q3/7D).

Baboudjian, M, Leni, R, Oderda, M, Peyrottes, A, Kesch, C, Al-Nader, M, Uleri, A, Dariane, C, Baud, H, Olivier, J, Rios, AR, Sanguedolce, F, Benard, V, Windisch, O, Valerio, M, Gandaglia, G, Ploussard, G. Active Surveillance of Grade Group 2 Prostate Cancer: Oncological Outcomes from a Contemporary European Cohort. European Urology Oncology. 2025; 8(5)DOI:10.1016/j.euo.2025.01.009. PMID:39965999. IF:9.300(Q1/1D).

Downes, MR, Lajkosz, K, Algaba, F, Allory, Y, Amin, MB, Cheng, L, Desai, S, Eckstein, M, Hartmann, A, Lopez-Beltran, A, Mannweiler, S, van Montfoort, ML, Oxley, J, Paner, GP, Samaratunga, H, Shen, S, Warrick, J, Williamson, SR, Wobker, SE, van der Kwast, TH. Interobserver reproducibility of a hybrid three-tier grading system of papillary nonmuscle invasive urothelial carcinoma: an international Uropathology study. HISTOPATHOLOGY. 2025; 87(5)DOI:10.1111/his.15438. PMID:40058790. IF:4.100(Q1/1D).